Related references
Note: Only part of the references are listed.Implementation and impact of a multidisciplinary coagulation factor stewardship program at an academic medical center
Anem Waheed et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Systems-based hematology: highlighting successes and next steps
Jori E. May et al.
BLOOD ADVANCES (2020)
The effect of hospital-based antithrombotic stewardship on adherence to anticoagulant guidelines
Albert R. Dreijer et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2019)
The Development and Impact of Hemostatic Stewardship Programs
Kathryn E. Dane et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum
Adam Cuker et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program
Amichai Perlman et al.
ISRAEL JOURNAL OF HEALTH POLICY RESEARCH (2019)
Implementation of a hemophilia management program improves clinical outcomes
Giles W. Slocum et al.
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2019)
Continuous infusion of coagulation factor concentrates during intensive treatment
P. A. Holme et al.
HAEMOPHILIA (2018)
Fixed dose 4-factor prothrombin complex concentrate for the emergent reversal of warfarin: a retrospective analysis
Greta Astrup et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
The socioeconomic burden of patients affected by hemophilia with inhibitors
Lucia S. D'Angiolella et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
EVALUATION OF FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR EMERGENT WARFARIN REVERSAL IN PATIENTS WITH INTRACRANIAL HEMORRHAGE
Rachael Scott et al.
JOURNAL OF EMERGENCY MEDICINE (2018)
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
J. Mahlangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Identification of Cost-Saving Opportunities for the Use of Antithrombin III in Adult and Pediatric Patients
Alana Ciolek et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
The scope and value of an anticoagulation stewardship program at a community teaching hospital
Maura K. Wychowski et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis
Rahat Amadkhan Abdoellakhan et al.
NEUROCRITICAL CARE (2017)
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Johannes Oldenburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Use of Bypassing Agents and Risk of Thromboembolic Events in Patients with Haemophilia and Inhibitors
Katsiaryna Bykov et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Clinical Outcomes of a Pharmacy-Led Blood Factor Stewardship Program
Anne O. Trueg et al.
AMERICAN JOURNAL OF THERAPEUTICS (2017)
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
Jennifer A. Frontera et al.
NEUROCRITICAL CARE (2016)
US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
Nadine Shehab et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand
Darshan A. Mehta et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2016)
Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal
Lauren Klein et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2015)
Impact of an innovative blood factor stewardship program on drug expense and patient care
Lindsey B. Amerine et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2015)
Implementation of a Hemostatic and Antithrombotic Stewardship program
David P. Reardon et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2015)
Burden of illness: direct and indirect costs among persons with hemophilia A in the United States
Zheng-Yi Zhou et al.
JOURNAL OF MEDICAL ECONOMICS (2015)
Multidisciplinary initiative to improve inpatient anticoagulation and management of venous thromboembolism
Greg Maynard et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2014)
Impact of being underweight or overweight on factor VIII dosing in hemophilia A patients
Severine Henrard et al.
HAEMATOLOGICA (2013)
An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies
Nakisa Khorsand et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Anticoagulation-associated Adverse Drug Events
Gregory Piazza et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy
N. Khorsand et al.
TRANSFUSION MEDICINE (2011)
Delivery of optimized anticoagulant therapy: Consensus statement from the anticoagulation forum
David A. Garcia et al.
ANNALS OF PHARMACOTHERAPY (2008)
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study
Jan Astermark et al.
BLOOD (2007)
Intermittent injections vs. continuous infusion of Factor VIII in haemophilia patients undergoing major surgery
A Batorova et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
